Boston Scientific Announces Results For Second Quarter 2020
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- Oracle results beat estimates, but shares fall on plans for $40 billion raise
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Alibaba falls on China AI capex report; Citi says selloff is premature
- Crude Inventory Fell 7.2 Million Barrels Last Week, Says EIA
Boston Scientific (BSX) Tops Q2 EPS by 10c
July 29, 2020 6:38 AM EDTBoston Scientific (NYSE: BSX) reported Q2 EPS of $0.08, $0.10 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $2 billion versus the consensus estimate of $1.73 billion.
For earnings history and earnings-related data on Boston Scientific (BSX) click here.
... More